# MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer

> **NCT00706966** · NA · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 10 (actual)

## Conditions studied

- Nonmalignant Neoplasm
- Prostate Cancer

## Interventions

- **DRUG:** dutasteride

## Key facts

- **NCT ID:** NCT00706966
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-12
- **Final completion:** 2011-08
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2014-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00706966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00706966, "MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00706966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*